Presentation slides and video from the 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Community Clinicians were presented virtually on June 19, 2023.
Program Organizers
Target Audience
The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.
Program Learning Objectives
Summarize recent updates in the use of bispecific antibodies.
Identify PDL-1 inhibitors in the SCLC landscape.
Describe T-Cell therapies in hematological malignancies and emerging cellular therapies in solid tumors.
You can view the program agenda here.
Please note on-demand recordings are not available for continuing education credits.
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Community Clinicians; Presenter: Natalie Callander, MD; Date: June 19, 202300:16:33
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Community Clinicians; Presenter: Natalie Callander, MD; Date: June 19, 202300:26:53
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Community Clinicians; Presenter: Sandip Patel, MD; Date: June 19, 202300:05:28
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Community Clinicians; Presenter: Sandip Patel, MD; Date: June 19, 202300:17:35
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us